Alzheimer's brain change measured in humans

June 12, 2013
Mutations in PSEN1 and PSEN2, the enzymatic components of gamma-secretase, increase the rate of production of Aβ42 peptides (yellow arrow). The soluble Aβ peptides may be irreversibly lost (red arrows) by retrograde transport across the blood brain barrier, transfer into the CSF, or by degradation within the brain. The soluble Aβ peptides may also be deposited into plaques, either directly or via a reversible exchange process (blue arrows). The reversible exchange process is kinetically distinct from the irreversible losses. Credit: Randall Bateman/Familial Adult Children Study (5P01AG026276-S1)

Scientists at Washington University School of Medicine in St. Louis have measured a significant and potentially pivotal difference between the brains of patients with an inherited form of Alzheimer's disease and healthy family members who do not carry a mutation for the disease.

Researchers have known that amyloid beta, a , builds up into plaques in the brains of Alzheimer's patients. They believe the plaques cause the and other that characterize the disease. Normal produces different forms of amyloid beta.

The new study shows that research participants with that cause early-onset Alzheimer's make about 20 percent more of a specific form of amyloid beta – known as amyloid beta 42 – than family members who do not have the Alzheimer's mutation.

Scientists found another, more surprising difference linked to amyloid beta 42 in mutation carriers: signs that amyloid beta 42 drops out of the cerebrospinal fluid much more quickly than other forms of amyloid beta. This may be because amyloid beta 42 is being deposited on .

"These results indicate how much we should target amyloid beta 42 with Alzheimer's drugs," said Randall Bateman, MD, the Charles F. and Joanne Knight Distinguished Professor of . "We are hopeful that this and other research will lead to preventive therapies to delay or even possibly prevent Alzheimer's disease."

The study appears June 12 in Science Translational Medicine.

In addition to helping develop treatments for inherited Alzheimer's, investigations of these conditions have helped scientists lay the groundwork for advances in treatment of the much more common sporadic forms of the disease.

Three forms account for most of the amyloid beta found in the cerebrospinal fluid: amyloid beta 38, 40 and 42. Earlier studies of the after death and using animal research had suggested that amyloid beta 42 was the most important contributor to Alzheimer's. The new study not only confirms this connection but also quantifies overproduction of amyloid beta 42 for the first time in living human brains.

Bateman, who co-developed a technique that measures the rate at which amyloid beta is produced and cleared from the , contacted several Washington University colleagues to see if they could develop a way to analyze the types of amyloid beta being produced in the brain.

Bateman, metabolism expert Bruce Patterson, PhD, and biomedical engineer Donald Elbert, PhD, created a new mathematical model to describe the production and clearance of amyloid beta.

The scientists applied the model to data from 11 research participants with Alzheimer's mutations and 12 related family members who did not have the genetic errors that cause Alzheimer's. The model let the scientists compare the production rates of the protein's different forms, revealing an increase in amyloid beta 42 production in subjects with an Alzheimer's gene.

"Working in isolation, any one of us would likely have gotten the wrong answer, or no answer," Elbert said. "Bringing our different skill sets together let us tackle a very complex physiological problem."

Scientists are testing the new model on data from approximately 100 Alzheimer's patients.

"We hope that our new insights about the production and clearance of amyloid beta proteins will pave the way for future studies aimed at understanding and altering the metabolic processes that underlie this devastating disease," Patterson said.

Explore further: New perspective needed for role of major Alzheimer's gene

More information: "Increased in Vivo Amyloid-β42 Production, Exchange, and Irreversible Loss in Presenilin Mutations Carriers," by R. Potter et al. Science Translational Medicine, 2013.

Related Stories

New perspective needed for role of major Alzheimer's gene

May 7, 2013
(Medical Xpress)—Scientists' picture of how a gene strongly linked to Alzheimer's disease harms the brain may have to be revised, researchers at Washington University School of Medicine in St. Louis have found.

Bursts of brain activity may protect against Alzheimer's disease

April 18, 2013
Evidence indicates that the accumulation of amyloid-beta proteins, which form the plaques found in the brains of Alzheimer's patients, is critical for the development of Alzheimer's disease, which impacts 5.4 million Americans. ...

Amyloid beta in the brain of individuals with Alzheimer's disease

March 30, 2012
While there may not be a consensus whether deposition of amyloid beta contributes to Alzheimer's disease or is a consequence of it, there is agreement that something else is promoting the process. Other proteins are often ...

A new strategy required in the search for Alzheimer's drugs?

May 24, 2013
In the search for medication against Alzheimer's disease, scientists have focused – among other factors – on drugs that can break down Amyloid beta (A-beta). After all, it is the accumulation of A-beta that causes the ...

Genetic markers ID second Alzheimer's pathway

April 4, 2013
Researchers at Washington University School of Medicine in St. Louis have identified a new set of genetic markers for Alzheimer's that point to a second pathway through which the disease develops.

A molecular chain reaction in Alzheimer's disease

May 29, 2013
Researchers at Lund University in Sweden have identified the molecular mechanism behind the transformation of one of the components in Alzheimer's disease. They identified the crucial step leading to formations that kill ...

Recommended for you

Artificial intelligence predicts dementia before onset of symptoms

August 22, 2017
Imagine if doctors could determine, many years in advance, who is likely to develop dementia. Such prognostic capabilities would give patients and their families time to plan and manage treatment and care. Thanks to artificial ...

Chronic stress induces fatal organ dysfunctions via a new neural circuit

August 22, 2017
Hokkaido University researchers revealed that fatal gut failure in a multiple sclerosis (MS) mouse model under chronic stress is caused by a newly discovered nerve pathway. The findings could provide a new therapeutic strategy ...

Noninvasive eye scan could detect key signs of Alzheimer's years before patients show symptoms

August 17, 2017
Cedars-Sinai neuroscience investigators have found that Alzheimer's disease affects the retina—the back of the eye—similarly to the way it affects the brain. The study also revealed that an investigational, noninvasive ...

Could olfactory loss point to Alzheimer's disease?

August 16, 2017
By the time you start losing your memory, it's almost too late. That's because the damage to your brain associated with Alzheimer's disease (AD) may already have been going on for as long as twenty years. Which is why there ...

New Machine Learning program shows promise for early Alzheimer's diagnosis

August 15, 2017
A new machine learning program developed by researchers at Case Western Reserve University appears to outperform other methods for diagnosing Alzheimer's disease before symptoms begin to interfere with every day living, initial ...

Brain scan study adds to evidence that lower brain serotonin levels are linked to dementia

August 14, 2017
In a study looking at brain scans of people with mild loss of thought and memory ability, Johns Hopkins researchers report evidence of lower levels of the serotonin transporter—a natural brain chemical that regulates mood, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.